For researchers in the know!
Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend. Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research.
Are You New To Nanomedicine?
Information about nanomedicine for people without background knowledge in science is provided. Provides an introduction to nanomedicine, an overview of the nanomedicines currently in clinical use, a glossary of sciencitifc terms often used in nanomedicine and a section on frequently asked questions.
Everything teachers and pupils need to know about Nanomedicine
Fun and simple classroom activities are available for teaching and learning about the key principles of nanotechnology as well as short videos to help with explanations. Up to date nanonews and brief explanations of current research involving nanomedicine are also available.
Welcome to the British Society for Nanomedicine
With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK
The second annual British Society for Nanomedicine Early Career Researchers' meeting will be held at Swansea University on the 11th and 12th of August.
The Meeting will have availability for >35 oral presentations, a large poster session, social programme and 2 plenary speakers. The full two day meeting covers all areas of Nanomedicine with prizes for oral and poster presentations. All abstracts will be published as a Journal of Interdisciplinary Nanomedicine special edition.
DEADLINE FOR REGISTRATION AND ABSTRACTS - 30 JUNE 2016
Editors-in-Chief Steve Rannard, Raj Bawa, Si-Shen Feng and Andrew Owen
The Journal of Interdisciplinary Nanomedicine (JOIN) is an international peer-reviewed academic journal that aims to provide truly interdisciplinary nanomedicine research. JOIN is now accepting submissions from all relevant fields to be included in the first issue.
The journal contains evidence-based research and translational outputs with high-level contributions from at least two sciences that are peer-reviewed by multiple reviewers tasked to focus primarily on their specialist areas. Multiple first and/or corresponding author status is encouraged so as to provide transparency and acknowledgment for contribution to multidisciplinary work. The Journal embraces submissions from all relevant fields as applied to early stage scientific developments and studies aimed at the progression of nanomedicines towards the clinic, which include engineering, science and medicine, especially materials sciences, life science, clinical science, intellectual property, regulatory issues and policy considerations. JOIN contains original research papers, editorials, review articles, technical notes, and letters to the editor about matters that may benefit the wider readership. Advances that are progressing to application through consolidation of multiple areas of expertise are especially encouraged. Core areas of particular interest include applications of new materials and biological concepts, targeted delivery, molecular biomaterials and nanotechnology in diagnostics, pharmacology, pharmaceutics, toxicology, and clinical outcomes.
For further details please look here
APS Conference Report:-Emerging nanomedicine applications and manufacturing: progress and challenges
6th APS International PharmSci Conference 7–9 September 2015 East Midlands Conference Centre, University of Nottingham, Nottingham, UK.
The APS is pleased to announce that, a conference report written jointly by members of the APS Nanomedicines focus group and the British Society for Nanomedicine (BSNM) has been published.The Academy of Pharmaceutical Sciences (APS) and the British Society for Nanomedicine (BSNM) organized a one-day session as part of the annual APS PharmSci conference, to discuss some of the latest developments in nanomedicine particularly in the areas of cancer, infection and targeting of the CNS. The meeting report can be accessed via the following link:
For details of this year’s PharmSci conference please visit http://www.ukpharmsci.org/